$2.22 -0.11 (-4.72%)
11/30/2009 10:04 AM

DURECT Corp (DRRX)

CAPS Rating: 3 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Featured Broker Partners